Profound Medical Corp PROF

Primary Symbol: T.PRN

Healthcare Medical Devices

Profound Medical Corp. is a Canada-based commercial-stage medical device company that develops and markets customizable, incision-free therapies for the ablation of diseased tissue. It is commercializing TULSA-PRO, a technology that combines real-time magnetic resonance imaging (MRI), robotically driven transurethral ultrasound and closed-loop temperature feedback control. The TULSA procedure, performed using the TULSA-PRO system, has the potential of becoming a mainstream treatment modality across the entire prostate disease spectrum; ranging from low -, intermediate-, or high-risk prostate cancer; to hybrid patients suffering from both prostate cancer and benign prostatic hyperplasia (BPH); to men with BPH only; and also, to patients requiring salvage therapy for radio-recurrent localized prostate cancer. It is also commercializing Sonalleve, a therapeutic platform that is CE marked for the treatment of uterine fibroids and palliative pain treatment of bone metastases.

TSX:PRN - Post by User

Profound Medical Corp

<< Previous

Bullboard Posts

Next >>

Post by MrMugsyon May 21, 2021 8:58am

216 Views

Post# 33246840

CEO taking advantage of the lower share price ...

Filed 2021-05-20 11:43 Tx date 2021-05-20	$PRN Profound Medical Corp. (formerly Mira IV Acquisition Corp.)	Menawat, Dr., Arun 4 - Director of Issuer, 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$57,000 +3,000 vol $19.00 each	246,988
Filed 2021-05-20 11:43 Tx date 2021-05-20	$PRN Profound Medical Corp. (formerly Mira IV Acquisition Corp.)	Menawat, Dr., Arun 4 - Director of Issuer, 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$36,568 +2,000 vol $18.28 each	243,988
Filed 2021-05-19 14:58 Tx date 2021-05-19	$PRN Profound Medical Corp. (formerly Mira IV Acquisition Corp.)	Ellacott, Brian 4 - Director of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$319,793 +18,000 vol $17.77 each	18,000